Treatment Trials

3 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
      Description

      The purpose of this research is to learn if Obinutuzumab is effective and safe in treating patients with fibrillary glomerulonephritis (FGN).

      Conditions
      Fibrillary Glomerulonephritis
      Talk to us
      COMPLETED
      Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis
      Description

      This pilot study is being done to see if the study medication, Rituximab, preserves kidney function after 12 months of taking the drug.

      Conditions
      Fibrillary Glomerulonephritis
      Talk to us
      UNKNOWN
      A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
      Description

      A Multicenter, Comparative Safety and Efficacy Study of Acthar gel alone or in combination with oral Tacrolimus to reduce urinary proteinuria in patients with idiopathic DNAJB9 Positive Fibrillary glomerulopathy.

      Conditions
      Fibrillary Glomerulonephritis
      Talk to us